Royal Sense (544143)

Score breakdown: P/E: 3/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Sales grew 97.46% and profit grew 70.59%, showing strong momentum
• P/E of 11.47 and PEG of 0.14 indicate the stock is not expensive relative to growth
• ROCE of 35.18% reflects efficient use of capital
• Piotroski F-Score of 7/9 suggests improving financial health

Concerns

• Promoter holding, book value, ROE, and debt/equity are unavailable, creating a governance and balance sheet blind spot
• Zero dividend yield gives no cash return while waiting for value to be recognized
• Price is down sharply from the 52-week high of ₹309.75, indicating market skepticism or volatility
• High growth in a microcap may be temporary or order-driven, with no clear evidence of a durable moat

AI Analysis

Let me examine Royal Sense the way I would examine any business: through the lens of durable economics, honest numbers, and a margin of safety. It is a small medical equipment supplier with a market cap of just ₹68 Cr. The immediate attraction is growth: sales up 97.46% and profits up 70.59%. At ₹139, the P/E is only 11.47, and the PEG ratio of 0.14 suggests the market is paying very little for that growth. That is interesting, but I do not buy a business simply because the screen looks cheap. The ROCE of 35.18% is genuinely strong. A company can earn a high return on capital only if it has some real advantage or excellent execution. The Piotroski F-Score of 7/9 also tells me the financial health is improving, not deteriorating. The latest quarter shows sales of ₹43 Cr and net profit of ₹4 Cr, which means a net margin of roughly 9.3% — respectable for a capital-intensive sector, though not spectacular. What troubles me is what is missing. Book value, debt-to-equity, ROE, and promoter holding are all unknown. For a microcap in India, promoter ownership is vital. No dividend means the investor must rely entirely on growth and future capital allocation. The share price sits near the bottom of its 52-week range of ₹122.05 to ₹309.75, down sharply from the high. That may be an opportunity, or it may be the market sensing a slowdown. I see real growth, but I do not yet see a wide moat or a proven, durable franchise. High growth from a small base can fade quickly. So while Royal Sense looks statistically cheap, the missing governance and balance sheet details leave me uncomfortable. I would keep it on the watch list, not in the portfolio.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer